Karyopharm Therapeutics | KPTI - Capital Ordinário

Preço das Ações
9.36
Mudança Diária
-0.05 -0.53%
Mensal
29.82%
Anual
53.19%
Q2 Previsão
8.59




Capital Ordinário Alterar Data
AbbVie USD 1.77B 1.75B 2025-06
Abbott USD 1.74B 23.39B 2025-09
Amgen USD 540M 1000K 2026-03
AstraZeneca USD 1.55B 73K 2026-03
BioCryst Pharmaceuticals USD 213.06M 2.54M 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Eli Lilly USD 943.5M 3.33M 2026-03
Enanta Pharmaceuticals USD 212K 1000 2023-12
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Incyte USD 199.95M 1.49M 2026-03
J&J USD 2.41B 1.74M 2025-12
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
MacroGenics USD 63.32M 60K 2025-12
Merck USD 2.47B 12.72M 2025-12
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Novartis USD 1.91B 60K 2026-03
Novartis USD 1.91B 10.64M 2025-12
Pfizer USD 5.7B 13M 2026-03
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Takeda JPY 1.58B 2K 2025-12
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
TG Therapeutics USD 155.21M 2.81M 2025-09
Ultragenyx Pharmaceutical USD 98.3M 1.7M 2026-03
Xencor USD 71.87M 529K 2025-12